|
[1]Racanelli V, Rehermann B.The liver as an immunological organ[J].Hepatology, 2006, 43:S54-S62.
|
|
[2]Doherty DG, O'Farrelly C.Innate and adaptive lymphoid cells in the human liver[J].Immunol Rev, 2000, 174:5-20.
|
|
[3]Wick MJ, Leithauser F, Reimann J.The hepatic immune system[J].Crit Rev Immunol, 2002, 22:47-103.
|
|
[4]Lanier LL.NK cell recognition[J].Annu Rev Immunol, 2005, 23:225-274.
|
|
[5]Vermijlen D, Luo D, Froelich CJ, et al.Hepatic natural killer cells ex-clusively kill splenic/blood natural killerresistant tumor cells by the perforin/granzyme pathway[J].J Leukoc Biol, 2002, 72:668-676.
|
|
[6]Ishiyama K, Ohdan H, Ohira M, et al.Difference in cytotoxicity a-gainst hepatocellular carcinoma between liver and periphery natural killer cells in humans[J].Hepatology, 2006, 43:362-372.
|
|
[7]Subleski JJ, Hall VL, Back TC, et al.Enhanced antitumor response by divergent modulation of natural killer and natural killer Tcells in the liver[J].Cancer Res, 2006, 66:11005-11012.
|
|
[8]Chen Y, Wei H, Gao B, et al.Activation and function of hepatic NK cells in hepatitis B infection:an underinvestigated innate immune re-sponse[J].J Viral Hepat, 2005, 12:38-45.
|
|
[9]Khakoo SI, Thio CL, Martin MP, et al.HLAand NKcell inhibitory re-ceptor genes in resolving hepatitis C virus infection[J].Science, 2004, 305:872-874.
|
|
[10]Sun R, Gao B.Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma) [J].Gastroenter-ology, 2004, 127:1525-1539.
|
|
[11]Radaeva S, Sun R, Jaruga B, et al.Natural killer cells ameliorate liv-er fibrosis by killing activated stellate cells in NKG2D dependent and tumor necrosis factor-related apoptosis-inducing liganddependent manners[J].Gastroenterology, 2006, 130:435-452.
|
|
[12]Melhem A, Muhanna N, Bishara A, et al.Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC[J].J Hepatol, 2006, 45:60-71.
|
|
[13]Kronenberg M.Toward an understanding of NKT cell biology:pro-gress and paradoxes[J].Annu Rev Immunol, 2005, 23:877-900.
|
|
[14]Exley MA, Koziel MJ.To be or not to be NKT:NKTcells in the liv-er[J].Hepatology, 2004, 40:1033-1040.
|
|
[15]Kennedy J, Rossi DL, Zurawski SM.et al.Mouse IL-17:a cyto-kine preferentially expressed by ab TCR+CD4-CD8-Tcells[J].J.Interferon Cytokine Res, 1996, 16:611-617.
|
|
[16]Steinman L.A brief history of TH17, the first major revision in the TH1/TH2hypothesis of T cell-mediated tissue damage[J].Nat.Med, 2007, 13:139-145.
|
|
[17]Swain MG.Hepatic NKT cells:friend or foe-[J].Clin Sci (Lond) .2008, 114 (7) :457-466.
|
|
[18]Kakimi K, Guidotti LG, Koezuka Y, et al.Natural killer Tcell acti-vation inhibits hepatitis B virus replication in vivo[J].J.Exp.Med, 2000, 192:921-930.
|
|
[19]Baron JL, Gardiner L, Nishimura S, et al.Activation of a nonclassical NKTcell subset in a transgenic mouse model of hepatitis B virus in-fection[J].Immunity, 2002, 16:583-594.
|
|
[20]Williams LM, Rudensky AY.Maintenance of the Foxp3dependent developmental program in mature regulatory T cells requires contin-ued expression of Foxp3[J].Nat Immunol, 2007, 8 (3) :277-284.
|
|
[21]Tang TJ, Kwekkeboom J, Mancham S, et al.Intrahepatic CD8+T-lymphocyte response is important for therapy-induced viral clear-ance in chronic hepatitis B infection[J].J.Hepatol, 2005, 43:45-52.
|
|
[22]Nuti S, Rosa D, Valiante NM, et al.Dynamics of intra-hepatic lymphocytes in chronic hepatitis C:enrichment for Va24+T cells and rapid elimination of effector cells by apoptosis[J].Eur J Immu-nol, 1998, 28:3448-3455.
|
|
[23]Lucas M, Gadola S, Meier U, et al.Frequency and phenotype of cir-culating Va24/Vb11double-positive natural killer T cells during hepatitis C virus infection[J].J Virol, 2003, 77:2251-2257.
|
|
[24]Terabe M, Berzofsky JA.Immunoregulatory Tcells in tumor immuni-ty[J].Curr Opin Immunol, 2004, 16:157-162.
|
|
[25]Miyagi T, Takehara T, Tatsumi T, et al.CD1d-mediated stimulation of natural killer Tcells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver[J].Int J Cancer, 2003, 106:81-89.
|
|
[26]Margalit M, Shibolet O, Klein A, et al.Suppression of hepatocellularcarcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes[J].Int J Cancer, 2005, 115:443-449.
|
|
[27]Seki S, Hashimoto W, Ogasawara K, et al.Antimetastatic effect of NK1+Tcells on experimental haematogenous tumour metastases in the liver and lungs of mice[J].Immunology, 1997, 92:561-566.
|
|
[28]Nakagawa R, Nagafune I, Tazunoki Y, et al.Mechanisms of the anti-metastatic effect in the liver and of the hepatocyte injury induced by a-galactosylceramide in mice[J].J Immunol, 2001, 166:6578-6584.
|
|
[29]Born WK, Reardon CL, O'Brien RL.The function of gammadelta T cells in innate immunity[J].Curr Opin Immunol, 2006, 18:31-38.
|
|
[30]Janeway CA Jr, Medzhitov R.Innate immune recognition[J].Annu RevImmunol, 2002, 20:197-216.
|
|
[31]Akira S, Takeda K.Toll-like receptor signaling[J].Nat Rev Im-munol, 2004, 4:499-511.
|
|
[32]Meylan E, Tschopp J, Karin M.Intracellular pattern recognition re-ceptorsin the host response[J].Nature, 2006, 442:39-44.
|
|
[33]Gustot T, Lemmers A, Moreno C, et al.Differential liver sensitization to toll-like receptor pathways in micewith alcoholic fatty liver[J].hepatology, 2006, 43:989-1000.
|
|
[34]Szabo G, Dolganiuc A, Mandrekar P.Pattern recognition receptors:acontemporary view on liver diseases[J].hepatology, 2006, 44:287-298.
|
|
[35]Schwabe RF, Seki E, Brenner DA.Toll-like receptor signaling in the liver[J].Gastroenterology, 2006, 130:1886-1900.
|
PDF下载 ( 213 KB)
本文二维码
下载:
